Official Gene Symbol | Other Aliases |
---|---|
XPNPEP1 | XPNPEPL, XPNPEPL1 |
Sequence Length (AA) | Molecular Weight (Da) |
---|---|
623 | 69918 |
Protein Name |
---|
Xaa-Pro aminopeptidase 1 |
Sources | |
---|---|
UniProt PhosphoSitePlus ® GeneCards |
Human Protein Atlas |
10 | 20 | 30 | 40 | 50 |
MPPKVTSELL | RQLRQAMRNS | EYVTEPIQAY | IIPSGDAHQS | EYIAPCDCRR |
60 | 70 | 80 | 90 | 100 |
AFVSGFDGSA | GTAIITEEHA | AMWTDGRYFL | QAAKQMDSNW | TLMKMGLKDT |
110 | 120 | 130 | 140 | 150 |
PTQEDWLVSV | LPEGSRVGVD | PLIIPTDYWK | KMAKVLRSAG | HHLIPVKENL |
160 | 170 | 180 | 190 | 200 |
VDKIWTDRPE | RPCKPLLTLG | LDYTGISWKD | KVADLRLKMA | ERNVMWFVVT |
210 | 220 | 230 | 240 | 250 |
ALDEIAWLFN | LRGSDVEHNP | VFFSYAIIGL | ETIMLFIDGD | RIDAPSVKEH |
260 | 270 | 280 | 290 | 300 |
LLLDLGLEAE | YRIQVHPYKS | ILSELKALCA | DLSPREKVWV | SDKASYAVSE |
310 | 320 | 330 | 340 | 350 |
TIPKDHRCCM | PYTPICIAKA | VKNSAESEGM | RRAHIKDAVA | LCELFNWLEK |
360 | 370 | 380 | 390 | 400 |
EVPKGGVTEI | SAADKAEEFR | RQQADFVDLS | FPTISSTGPN | GAIIHYAPVP |
410 | 420 | 430 | 440 | 450 |
ETNRTLSLDE | VYLIDSGAQY | KDGTTDVTRT | MHFGTPTAYE | KECFTYVLKG |
460 | 470 | 480 | 490 | 500 |
HIAVSAAVFP | TGTKGHLLDS | FARSALWDSG | LDYLHGTGHG | VGSFLNVHEG |
510 | 520 | 530 | 540 | 550 |
PCGISYKTFS | DEPLEAGMIV | TDEPGYYEDG | AFGIRIENVV | LVVPVKTKYN |
560 | 570 | 580 | 590 | 600 |
FNNRGSLTFE | PLTLVPIQTK | MIDVDSLTDK | ECDWLNNYHL | TCRDVIGKEL |
610 | 620 | 623 | ||
QKQGRQEALE | WLIRETQPIS | KQH |
Data source: UniProt
Uniprot Database Entry PhosphoSitePlus ®
loading
Data source: Panorama
View Details (opens in a new window)
Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA. Schoenherr RM, Saul RG, Whiteaker JR, Yan P, Whiteley GR, Paulovich AG. Mol Cell Proteomics. 2015 Feb;14(2):382-98. doi: 10.1074/mcp.O114.043133. Epub 2014 Dec 15. PMID: 25512614
Data source: Panorama
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y5 (1+) | 16.3 | 5.7 | 5.6 | 31.1 | 23.8 | 23 | 35.1 | 24.5 | 23.7 | 15 | 15 | 15 |
y6 (1+) | 10.1 | 7.8 | 6.8 | 37.2 | 22.2 | 21.9 | 38.5 | 23.5 | 22.9 | 15 | 15 | 15 |
y10 (1+) | 17.3 | 6.9 | 8.2 | 31.8 | 20.9 | 21.1 | 36.2 | 22 | 22.6 | 15 | 15 | 15 |
sum | 13.7 | 5.3 | 5.5 | 30.9 | 22.2 | 22 | 33.8 | 22.8 | 22.7 | 15 | 15 | 15 |
Data source: Panorama
View Details (opens in a new window)
Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA. Schoenherr RM, Saul RG, Whiteaker JR, Yan P, Whiteley GR, Paulovich AG. Mol Cell Proteomics. 2015 Feb;14(2):382-98. doi: 10.1074/mcp.O114.043133. Epub 2014 Dec 15. PMID: 25512614
Data source: Panorama
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y7 (1+) | 34.2 | 18 | 14.6 | 37.5 | 27.1 | 29.5 | 50.8 | 32.5 | 32.9 | 15 | 15 | 15 |
y8 (1+) | 34.5 | 23.2 | 18.9 | 50.8 | 27.6 | 27.9 | 61.4 | 36.1 | 33.7 | 15 | 15 | 15 |
y10 (1+) | 46.3 | 15.4 | 10.3 | 32.5 | 30.6 | 28.1 | 56.6 | 34.3 | 29.9 | 15 | 15 | 15 |
sum | 30.1 | 12.5 | 8.2 | 34.2 | 24.7 | 26.2 | 45.6 | 27.7 | 27.5 | 15 | 15 | 15 |
Comments